False
June 26, 2025
Our latest news roundup reports on the Bayer-Tsinghua partnership expansion, GLP-1 diabetes treatments, and GSK EU acceptance of linerixibat.
3 min read
By Rob Coker
June 6, 2025
Our latest news roundup reports on Novartis’ prostate cancer trial, Sandoz’ osteoporosis biosimilars, and more.
4 min read
By Rob Coker
June 5, 2025
The IQVIA Institute’s latest report evaluates how well seven countries are prepared to support the complex infrastructure required for CAR T therapies.
5 min read
June 2, 2025
We speak with experts from Amgen and Henry Ford Health about the development and approval of Uplizna for IgG4-related disease.
9 min read
By Rob Coker
May 30, 2025
From bird flu to COVID-19 vaccines to alleged corruption in journals, we look into recent moves from US Health Secretary RFK Jr.
3 min read
By Rob Coker
May 30, 2025
Our latest news roundup reports on a new blow for Harvard, how Pfizer and Astellas’ Xtandi improves cancer survival, and more.
4 min read
May 29, 2025
We ask a company about lessons learned from the GMP certification process.
4 min read
May 28, 2025
A report attempts to unravel the many challenges that face business leaders. We discuss those inherent in – and unique to – the pharmaceutical industry, from supply chains to tariffs, and more.
7 min read
May 27, 2025
Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”, and an ever-shifting regulatory environment.
6 min read
By Tomasz Kostrzewski
May 26, 2025
The FDA says it wants to phase out mandatory animal testing requirements for drug approval. What comes next? We find out why a variety of different methods may be needed.
5 min read
False